RPL39 and central nervous system cancer: First, the CCK8 test was performed to detect the viability of glioma cells, and the results showed that RPL39 knockdown significantly reduced the viability of U251 and U87 cells, while RPL39 overexpression increased cell viability (Figure 11B).